Skip to content

PRECISION BIOSCIENCES INC

DTIL

CIK 0001357874 · Biological Products, (No Diagnostic Substances) · Nasdaq

← back to feed
Revenue (TTM)
$10.9M
−50.1% YoY Q1 Apr 2026
Net Income (TTM)
−$84.3M
−738.0% YoY Q1 Apr 2026
EPS Diluted (TTM)
−$6.93
−442.3% YoY Q1 Apr 2026
Gross Margin
—
Q1 Apr 2026
Operating Margin
-676.6%
Q1 Apr 2026
Net Margin
-773.5%
Q1 Apr 2026
Free Cash Flow (TTM)
−$82.12M
Q1 Apr 2026
Cash
$99.37M
Q1 Apr 2026
Total Debt
$22.27M
Q1 Apr 2026
Shares Outstanding
25.8M sh
Q1 Apr 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings